Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NuVasive gets $230mm via convertible debt sale

Executive Summary

NuVasive (minimally invasive devices for spine surgeries) raised $230mm (including the overallotment) through the sale of five-year 2.25% convertible senior notes to JP Morgan Securities and Goldman Sachs. The notes convert into NuVasive common shares at $44.74 each.
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Convertible Debt
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register